secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cyclo Therapeutics, Inc. (—)
CIK:        0000922247
Form:       8-K
Filed at:   2025-02-04T23:59:59+00:00
Accession:  0001437749-25-002723
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclo Therapeutics extends merger deadline to March 31, 2025 and issues $2M convertible note to Rafael
--------------------------------------------------------------------------------

- Merger Agreement End Date extended from Feb 15 to March 31, 2025 via Amendment No. 2 with Rafael Holdings.
- Company issued $2M convertible promissory note to Rafael (5% interest, matures March 31, 2025) for working capital.
- Prior notes' maturity dates also extended to March 31, 2025.
- Rafael Holdings owns ~39.5% of Cyclo common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/922247/000143774925002723/0001437749-25-002723-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/922247/000143774925002723/ctdh20250204_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-002723

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer